168 related articles for article (PubMed ID: 31213815)
1. Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury.
Wu P; Zhao H; Gou X; Wu X; Zhang S; Deng G; Chen Q
Int J Nanomedicine; 2019; 14():4059-4069. PubMed ID: 31213815
[No Abstract] [Full Text] [Related]
2. Engineered exosomes mediated targeted delivery of neuroprotective peptide NR2B9c for the treatment of traumatic brain injury.
Haroon K; Zheng H; Wu S; Liu Z; Tang Y; Yang GY; Liu Y; Zhang Z
Int J Pharm; 2024 Jan; 649():123656. PubMed ID: 38040392
[TBL] [Abstract][Full Text] [Related]
3. Activatable Protein Nanoparticles for Targeted Delivery of Therapeutic Peptides.
Yu X; Gou X; Wu P; Han L; Tian D; Du F; Chen Z; Liu F; Deng G; Chen AT; Ma C; Liu J; Hashmi SM; Guo X; Wang X; Zhao H; Liu X; Zhu X; Sheth K; Chen Q; Fan L; Zhou J
Adv Mater; 2018 Feb; 30(7):. PubMed ID: 29315863
[TBL] [Abstract][Full Text] [Related]
4. Conjugation of Therapeutic PSD-95 Inhibitors to the Cell-Penetrating Peptide Tat Affects Blood-Brain Barrier Adherence, Uptake, and Permeation.
Kristensen M; Kucharz K; Felipe Alves Fernandes E; Strømgaard K; Schallburg Nielsen M; Cederberg Helms HC; Bach A; Ulrikkaholm Tofte-Hansen M; Irene Aldana Garcia B; Lauritzen M; Brodin B
Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32674358
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke.
Li R; Huang Y; Chen L; Zhou H; Zhang M; Chang L; Shen H; Zhou M; Su P; Zhu D
Nanomedicine; 2019 Jun; 18():380-390. PubMed ID: 30428334
[TBL] [Abstract][Full Text] [Related]
6. A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries.
Mann AP; Scodeller P; Hussain S; Joo J; Kwon E; Braun GB; Mölder T; She ZG; Kotamraju VR; Ranscht B; Krajewski S; Teesalu T; Bhatia S; Sailor MJ; Ruoslahti E
Nat Commun; 2016 Jun; 7():11980. PubMed ID: 27351915
[TBL] [Abstract][Full Text] [Related]
7. Delayed Administration of Tat-HA-NR2B9c Promotes Recovery After Stroke in Rats.
Zhou HH; Tang Y; Zhang XY; Luo CX; Gao LY; Wu HY; Chang L; Zhu DY
Stroke; 2015 May; 46(5):1352-8. PubMed ID: 25851770
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor delivered to the brain using poly (lactide-co-glycolide) nanoparticles improves neurological and cognitive outcome in mice with traumatic brain injury.
Khalin I; Alyautdin R; Wong TW; Gnanou J; Kocherga G; Kreuter J
Drug Deliv; 2016 Nov; 23(9):3520-3528. PubMed ID: 27278330
[TBL] [Abstract][Full Text] [Related]
9. Porous Silicon Nanoparticles Targeted to the Extracellular Matrix for Therapeutic Protein Delivery in Traumatic Brain Injury.
Waggoner LE; Kang J; Zuidema JM; Vijayakumar S; Hurtado AA; Sailor MJ; Kwon EJ
Bioconjug Chem; 2022 Sep; 33(9):1685-1697. PubMed ID: 36017941
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of Da Chuanxiong Formula against cognitive and motor deficits in a rat controlled cortical impact model of traumatic brain injury.
Liu ZK; Ng CF; Shiu HT; Wong HL; Chin WC; Zhang JF; Lam PK; Poon WS; Lau CB; Leung PC; Ko CH
J Ethnopharmacol; 2018 May; 217():11-22. PubMed ID: 29425850
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic Analysis of Peptide-Modified Nanoparticles with Engineered Physicochemical Properties in a Mouse Model of Traumatic Brain Injury.
Waggoner LE; Madias MI; Hurtado AA; Kwon EJ
AAPS J; 2021 Aug; 23(5):100. PubMed ID: 34401968
[TBL] [Abstract][Full Text] [Related]
12. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor.
Bråtane BT; Cui H; Cook DJ; Bouley J; Tymianski M; Fisher M
Stroke; 2011 Nov; 42(11):3265-70. PubMed ID: 21903963
[TBL] [Abstract][Full Text] [Related]
14. Twin-Arginine Translocation Peptide Conjugated Epirubicin-Loaded Nanoparticles for Enhanced Tumor Penetrating and Targeting.
Zhang L; Liu F; Li G; Zhou Y; Yang Y
J Pharm Sci; 2015 Dec; 104(12):4185-4196. PubMed ID: 26398477
[TBL] [Abstract][Full Text] [Related]
15. Tat-NR2B9c prevents excitotoxic neuronal superoxide production.
Chen Y; Brennan-Minnella AM; Sheth S; El-Benna J; Swanson RA
J Cereb Blood Flow Metab; 2015 May; 35(5):739-42. PubMed ID: 25669908
[TBL] [Abstract][Full Text] [Related]
16. Cloning, expression, and purification of a recombinant Tat-HA-NR2B9c peptide.
Zhou HH; Zhang AX; Zhang Y; Zhu DY
Protein Expr Purif; 2012 Oct; 85(2):239-45. PubMed ID: 22944204
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of the PSD95 inhibitor Tat-NR2B9c in mice requires dose translation between species.
Teves LM; Cui H; Tymianski M
J Cereb Blood Flow Metab; 2016 Mar; 36(3):555-61. PubMed ID: 26661213
[TBL] [Abstract][Full Text] [Related]
18. Ascorbic Palmitate as a Bifunctional Drug and Nanocarrier of Paclitaxel for Synergistic Anti-Tumor Therapy.
Shi S; Yang L; Yao Q; Li X; Ming Y; Zhao Y
J Biomed Nanotechnol; 2018 Sep; 14(9):1601-1612. PubMed ID: 29958554
[TBL] [Abstract][Full Text] [Related]
19. Targeting of nanoparticles to the cerebral vasculature after traumatic brain injury.
Omo-Lamai S; Nong J; Savalia K; Kelley BJ; Wu J; Esteves-Reyes S; Chase LS; Muzykantov VR; Marcos-Contreras OA; Dollé JP; Smith DH; Brenner JS
PLoS One; 2024; 19(6):e0297451. PubMed ID: 38857220
[TBL] [Abstract][Full Text] [Related]
20. Apple-Derived Nanoparticles Modulate Expression of Organic-Anion-Transporting Polypeptide (OATP) 2B1 in Caco-2 Cells.
Fujita D; Arai T; Komori H; Shirasaki Y; Wakayama T; Nakanishi T; Tamai I
Mol Pharm; 2018 Dec; 15(12):5772-5780. PubMed ID: 30359033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
